News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
297 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Henry Schein Reports Record Third Quarter 2018 Financial Results
GAAP diluted EPS of $0.79 declined by 9.2% over prior-year GAAP diluted EPS
November 6, 2018
·
24 min read
Business
RXi Pharmaceuticals to Webcast Third Quarter 2018 Financial Results on Wednesday, November 14, 2018
RXi Pharmaceuticals Corporation today announced that it will report its financial results for the third quarter ended September 30, 2018.
November 6, 2018
·
1 min read
Biotech Bay
Menarini Adopts Veeva CRM to Enhance Field Engagement with Pharmacies and Improve Commercial Execution
Veeva CRM empowers field teams with the information they need for greater productivity
November 6, 2018
·
3 min read
Business
Exicure, Inc. Provides Update on Corporate Progress and Third Quarter 2018 Financial Results
Announced launch of a Phase1b/2 trial for AST-008, Exicure’s TLR9 agonist drug candidate designed for immuno-oncology applications.
November 6, 2018
·
9 min read
Business
Novanta Announces Financial Results for the Third Quarter 2018
Third Quarter 2018 GAAP Revenue of $160.8 million, up 10% year over year
November 6, 2018
·
29 min read
Drug Development
BerGenBio Reports ~80% Improvement in PFS of AXL-positive vs AXL-negative NSCLC Patients in Bemcentinib + KEYTRUDA PhII Combination Trial
Late breaking abstract at SITC: Analysis of first stage of phase II trial with selective AXL inhibitor bemcentinib + KEYTRUDA in previously treated advanced NSCLC patients
November 6, 2018
·
8 min read
Deals
Trimb Acquires a Portfolio of Skin Care Brands in Northern Europe
The portfolio includes several well-established and highly recognized brands
November 6, 2018
·
1 min read
Business
Biologist and Inventor Dr. Cliff Han Presents Groundbreaking Theory of Negative Trigger at Microbes and Beneficial Microbes Conference in San Francisco
Dr. Han recently presented the allergy and probiotic research that undergirds the science behind his prebiotic allergy solution, AllerPops (https://AllerPops.com or https://knozejr.com/) at the second annual Microbes and Beneficial Microbes Conference held in San Francisco.
November 6, 2018
·
3 min read
Job Trends
Sober Up® Detox Drink Partners with High Times Media to Create Exclusive CBD Conference
Conference to Feature Renowned CBD Industry Experts
November 6, 2018
·
1 min read
BioMidwest
Pareto Intelligence’s Engage Solution Modernizes Health Plan and Provider Communication
This innovative messaging solution helped one client achieve a 15% higher condition capture rate in the first six months of a risk documentation improvement campaign and realize $2.7 million in financial improvement to-date.
November 6, 2018
·
2 min read
Previous
5 of 30
Next